Article
Impact of HIV-1 pol diversity on drug resistance and its clinical implications.
Current opinion in infectious diseases - 1 Dec 2006
Kantor Rami
Abstract excerpt
PURPOSE OF REVIEW: HIV knowledge is based on subtype B, common in resource-rich settings, whereas globally non-B subtypes predominate. Inter-subtype pol diversity encompasses multiple genotypic differences among HIV variants, the consequence of which is unknown. This review summarizes publications from the past year relevant to the impact of HIV diversity on drug resistance evolution and its potential clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
